Genomics

Genomics, a child sector within Superscout's Biotech & Life Sciences category, encompasses the technologies and platforms that sequence, analyze, and apply genomic data for healthcare, agriculture, and research applications, including next-generation sequencing, single-cell genomics, spatial transcriptomics, gene editing tools, and the bioinformatics software that interprets genomic data. With 6 funders actively investing in genomics startups tracked in Superscout's database, the sector represents the data layer of precision medicine, where understanding an individual's genetic makeup guides diagnosis, treatment selection, and drug development.

The genomics investment thesis is driven by the continued decline in sequencing costs (a whole genome now costs under $200 to sequence) and the growing clinical utility of genomic data. Population-scale genomic databases are enabling the identification of genetic risk factors for complex diseases, pharmacogenomics is guiding drug selection based on individual genetic profiles, and liquid biopsy using circulating tumor DNA is transforming cancer diagnosis and monitoring. The convergence of genomics with AI is particularly powerful: machine learning models trained on large genomic datasets can identify disease-associated variants, predict drug response, and discover novel therapeutic targets.

For genomics founders, the 2025-2026 funding environment rewards companies with proprietary datasets, clear clinical applications, and the ability to navigate the complex regulatory and reimbursement landscape of genomic medicine.